INTERIM PRODUCT SUPPLY AGREEMENTInterim Product Supply Agreement • March 31st, 2022 • Legend Biotech Corp • Pharmaceutical preparations
This Interim Product Supply Agreement (the “Agreement”) is made as of February 28th, 2022 (“Agreement Date”) by and between, on the one hand, Legend Biotech USA, Inc., a Delaware corporation (“Legend”) and Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“JPI” and, together with Legend, the “Parties”).
